LATS1/2-inactivation and consequent nuclear YAP/TAZ hyperactivation in the mammary epithelium drives the development of a pro ...

Tetralogy of Fallot (TOF) is a combination of four congenital (present at birth) heart defects that affect infants and children. The defects occur together and change the way blood flows through the ...

Adolphi, C. and Sosonkina, M. (2025) Machine Learning and Simulation Techniques for Detecting Buoy Types from LiDAR Data. Journal of Intelligent Learning Systems and Applications, 17, 8-24. doi: ...

Tickets for all 2025 Ampol State of Origin and Ampol Women’s State of Origin Series matches, along with the Men’s and Women’s Under-19’s State of Origin fixtures are now on sale.

This image provided by Blue Origin shows New Shepard seconds after takeoff in West Texas, Tuesday, Feb. 4, 2025. (Blue Origin via AP) This image provided by Blue Origin shows New Shepard on the pad ...

This image provided by Blue Origin shows New Shepard seconds after takeoff in West Texas, Tuesday, Feb. 4, 2025. (Blue Origin via AP) ...

Blue Origin's famed New Shepard spacecraft successfully simulated the moon's low gravity on board its capsule during a brief flight Tuesday morning over West Texas. Video of the uncrewed launch ...

A Blue Origin spacecraft will attempt to mimic lunar gravity in a daring maneuver during a planned Tuesday morning launch from West Texas. The New Shepard vehicle was developed by billionaire Jeff ...

Blue Origin will launch its first suborbital rocket launch of 2025 today — and attempt a wild spin trick to mimic the moon's gravity during the flight — but if you want to see it live ...

As of February 2025, India is ranked 12th among the world's most powerful countries. Forbes has released its 2025 list of the world’s 10 most powerful countries, with the United States leading ...

One of three parachutes did not initially inflate but did fully open before landing. Credit: Blue Origin webcast Updated 2:40 p.m. Eastern with Blue Origin statement. MOUNTAIN VIEW, Calif.

Image credit: Shutterstock/Tada Images. Thermo Fisher is cutting the headcount at two of its US facilities by 300 as the company continues to overhaul its viral vector manufacturing output.